Zenergy Power plc, the specialist manufacturer and developer of commercial applications for high-temperature superconductive (HTS) materials, is pleased to announce that it has been awarded a 475,000 euroe grant by the European Commission in support of its research into the development of low-cost production techniques for 2G HTS wires.
Taiwan Semiconductor Manufacturing Company (TSMC) today announced volume production of the first semiconductor foundry 40nm logic manufacturing process with the successful ramp of its 40 nanometer General Purpose (G) and Low Power (LP) versions.
Protein Forest, a leading developer of state-of-the-art sample fractionation technology and bioinformatics software for protein research, has announced that it has commenced shipments of its new digital ProteomeChip protein separation system.
A grant of $3.5 million from the State of Texas will give a major boost to NanoMedical Systems Inc., an Austin company that is developing an innovative method of delivering medications through an under-the-skin device that uses nanotechnology.
PharmaForm, a pharmaceutical product development, manufacturing and analytical testing services company, today announced the launch of its new Evaporative Precipitation into Aqueous Solution (EPAS) drug delivery technology at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.
Cambridge Research Laboratory of Toshiba Research Europe Ltd has developed a novel, label-free biosensor platform, which is expected to significantly shorten the total biomolecular assay process, saving days or even weeks of research time.
BudgetSensors announces the commercial introduction of the 'Tipless All-In-One AFM Probe' - a tipless version of the recently introduced versatile silicon AFM probe with 4 different cantilevers on a single holder chip.
The combination of the Berlin based drug delivery company Capsulution Nanoscience AG and the Magdeburg based biopharmaceutical company NanoDel Technologies GmbH under the name Capsulution Pharma AG creates a top-class company in the field of nanoparticle based drug delivery and drug development.
Midatech Group, a world leader in nanotechnology, today announces the formation of a Basel-based Swiss drug development subsidiary, PharMida AG. The mandate of PharMida is to develop a strong portfolio of clinically validated gold nanoparticle-drug combinations.
LDK Solar Co., Ltd., a leading manufacturer of multicrystalline solar wafers, has announced that it has signed a three-year contract to supply multicrystalline solar wafers to BP Solar International, Inc.